Dave Matthews
Chief Financial Officer
Finance and Marketing
Contextual Genomics
Canada
Biography
Mr. Matthews has spent the last 25 years as a senior finance executive in the life sciences industry. He has worked with companies ranging from start-ups through to large, profitable multinationals in North America and Europe, including Allelix Biopharmaceuticals (now part of Shire plc) and Aspreva Pharmaceuticals (acquired by Galenica) and has been closely involved in forming over a dozen corporate partnering and joint venture transactions with large pharmaceutical companies. Mr Matthews also has extensive capital markets experience completing a number of IPO’s and follow on financings, along with numerous private financings raising over $400 million with his companies.
Research Interest
Finance, Marketing, Sales and Investments
